Protocol Number:  VONO -103 
 
Official Title:   A Phase 1, Open- Label, Randomized, Crossover Study to Evaluate the  
Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan (20 mg) and 
Lansoprazole (30 mg) in Healthy Subjects  
 
Study ID: [REMOVED]  
 
Document Date: 15 -Apr-2021 